SHAREHOLDER INVOLVEMENT It was another busy year for Pro Vita Advisors in challenging corporations to respect and observe moral values. In addition to our Ford Motor (NYSE: F) shareholder proposal (see enclosed newsrelease), Pro Vita Advisors attempted shareholder proposals at American Express (NYSE: AXP), JP Morgan Chase (NYSE: JPM), Pfizer (NYSE: PFE), and Wells Fargo (NYSE: WFC). The year was unusual in that most of the shareholder proposals did not appear on the related corporate ballot for shareholder voting. At American Express, our proposal was voluntarily withdrawn. JP Morgan Chase was able to exclude our proposal on a technicality, and Pfizer fought successfully to keep us off their ballot by using the “ordinary business” argument with the Securities & Exchange Commission (SEC). However, the Wells Fargo resolution made the shareholder proxy for voting. Our Wells Fargo shareholder proposal was a direct challenge to the company’s support of the homosexual agenda. The proposal asked Wells Fargo, one of the nation’s largest banking institutions, “to formulate an equal employment policy …that does not make reference to any matters related to sexual interests, activities or orientation.” The proposal reads in part: - Whereas, it would be inappropriate and possibly illegal to ask a job applicant or employee about their sexual interests, inclinations and activities. - Whereas, unless an employee chooses to talk about their sexual interests or activities while working, the issue of sexual orientation is, essentially, moot. Therefore: While the legal institution of marriage between a man and a woman should be protected, the sexual interests of, inclinations and activities of all employees should be a private matter, not a corporate concern. Our Pfizer shareholder proposal challenging the company’s human embryonic stem cell (hESC) research may be the first of its kind. Although Pfizer successfully appealed to the SEC to keep our proposal off their shareholder voting proxy, we were pleased with our first attempt to defend life against research involving cells or cell lines resulting from the destruction of human embryos. The proposal follows. - Whereas, according to the company website, “At Pfizer research is conducted in accordance with longstanding ethical and clinical guidelines such as the Nuremberg Code (1947)…. Resolved, it is requested the Board of Directors form a committee to more fully explore the ethical and business implications of further research involving cells or cell lines that are the result of the destruction of human embryos. Pro Vita Advisors understands not every proposal will make the ballot, nonetheless, we are committed to shareholder involvement and believe every attempt to draw attention to the sanctity of human life is valuable.. |
IMPORTANT NOTICE TO SUBSCRIBERS AND READERS: The information in THE ADVISOR is intended solely to assist subscribers and readers in moral decision making. Pro Vita Advisors renders no opinion or recommendation regarding the economic/financial aspects of the securities of any company or industry mentioned.